CLSI C52:2017 (R2021)

CLSI C52:2017 (R2021)

Toxicology and Drug Testing in the Medical Laboratory, Third Edition, C52Ed3E

193,00 €

Details

Clinical and Laboratory Standards Institute guideline C52—Toxicology and Drug Testing in the Medical Laboratory helps medical
laboratories develop procedures for analyzing drugs of abuse and other compounds. C52 provides guidance on clinical toxicology
testing from the initial consultation through final result reporting and interpretation, and includes a variety of specimen types,
analytical procedures, and instrumentation.

This guideline discusses the most common purposes for clinical toxicology testing, including the support of emergency medicine,
obstetrics and gynecology, neonatology, pediatrics, psychiatry, pain management, and addiction medicine. The primary objective
is to ensure high-quality standards are maintained throughout the entire testing process, from specimen collection, processing, and
analysis, through results reporting and interpretation.

Zusätzliche Information

Autor Clinical and Laboratory Standards Institute (CLSI)
Veröffentlicht von CLSI
Document type Normen
Thema /subgroups/17901
Datum der Bestätigung 2021-01-01
EAN ISBN 1562388088
Seitenzahl 58
Ersetzt CLSI C52-A2
Schlagwort CLSI C52